Andrew is a Commercial Strategy professional with a decade of international experience in the Life Sciences sector. As a Strategy Insights & Planning Manager at ZS, he focuses on Go-To-Market strategy and product launches. He holds an MBA from IESE Business School.
He is passionate about accelerating care for patients with rare diseases through innovative, digital-first approaches.
Read the full overview →
Experience
15 Years
Current Role
Strategy Insights & Planning Manager
Job Level
Middle
Location
London, England, United Kingdom
Personality Overview
How Andrew shows up
ROI Seeker
Cost Conscious
Perfectionist
They are heavily focused on quality and prefer doing things the right way, even if it takes time. The only way to convince them is by showing them examples and ample proof. They are quite aware of their needs and limitations, so they are unlikely to over-promise.
Priorities
Topics Andrew cares about
Go-To-Market Strategy
A core area of his expertise, with 10 years of experience focusing on product launches for life science companies.
AI in Pharma
He actively shares content related to ZS's events and initiatives focused on creating AI-driven value for the pharmaceutical industry.
+5 more topicsLogin to view topics
Career
Work history
6-2019
Strategy Insights & Planning Manager
ZS
1-2018 - 6-2019
Strategy Insights & Planning Consultant
ZS
9-2015 - 12-2017
Strategy Insights & Planning Consultant
ZS
6-2014 - 8-2014
Summer Associate
Bain & Company
9-2011 - 8-2013
Sourcing Analyst
3M
In the press
Media appearances
ZS education sponsorship and career growth: Andrew’s story. Featured in ZS Insights
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Other ZS Employees
Explore more public profiles from related professionals.